Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2.
作者信息
Bayarri-Olmos Rafael, Johnsen Laust Bruun, Rosbjerg Anne, Helgstrand Charlotte, Bak-Thomsen Theresa, Garred Peter, Skjoedt Mikkel-Ole
机构信息
Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
Novo Nordisk A/S, Måløv, Denmark.
出版信息
J Biol Chem. 2021 Nov;297(5):101241. doi: 10.1016/j.jbc.2021.101241. Epub 2021 Oct 29.
Abstract
摘要
相似文献
1
Reply to Lassaunière: On the functional characterization of the Y453F RBD variant found in cluster 5 SARS-CoV-2.回复拉萨尼埃：关于在5型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）集群中发现的Y453F受体结合域（RBD）变体的功能特征
J Biol Chem. 2021 Nov;297(5):101241. doi: 10.1016/j.jbc.2021.101241. Epub 2021 Oct 29.
2
EFFECT OF RBD MUTATIONS IN SPIKE GLYCOPROTEIN OF SARS-COV-2 ON NEUTRALIZING IGG AFFINITY.SARS-CoV-2 刺突糖蛋白 RBD 突变对中和 IgG 亲和力的影响。
Georgian Med News. 2023 Jul-Aug(340-341):37-46.
3
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.SARS-CoV-2 Y453F 变异 mink 变体显示出 ACE-2 亲和力的明显增加，但不会挑战抗体中和。
J Biol Chem. 2021 Jan-Jun;296:100536. doi: 10.1016/j.jbc.2021.100536. Epub 2021 Mar 11.
4
Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.水貂 ACE2 与 SARS-CoV-2 及其水貂衍生变体结合的分子基础。
J Virol. 2022 Sep 14;96(17):e0081422. doi: 10.1128/jvi.00814-22. Epub 2022 Aug 24.
5
Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.人类针对 SARS-CoV-2 刺突蛋白受体结合域的中和抗体的结构基础。
Microbiol Spectr. 2021 Oct 31;9(2):e0135221. doi: 10.1128/Spectrum.01352-21. Epub 2021 Oct 13.
6
Characterization of SARS-CoV-2 Escape Mutants to a Pair of Neutralizing Antibodies Targeting the RBD and the NTD.SARS-CoV-2 逃逸突变体对靶向 RBD 和 NTD 的一对中和抗体的鉴定。
Int J Mol Sci. 2022 Jul 25;23(15):8177. doi: 10.3390/ijms23158177.
7
SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1.SARS-CoV-2 重组受体结合域（RBD）诱导针对 SARS-CoV-2 和 SARS-CoV-1 变异株的中和抗体。
Vaccine. 2021 Sep 24;39(40):5769-5779. doi: 10.1016/j.vaccine.2021.08.081. Epub 2021 Aug 26.
8
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.一种糖基化 RBD 蛋白诱导针对奥密克戎和其他变体的增强型中和抗体，提高对 SARS-CoV-2 感染的保护作用。
J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.
9
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.新冠病毒感染 14 个月后 COVID-19 恢复期患者结合抗体和中和抗体的动态分析。
Front Immunol. 2021 Nov 26;12:793953. doi: 10.3389/fimmu.2021.793953. eCollection 2021.
10
Generation and characterization of humanized synergistic neutralizing antibodies against SARS-CoV-2.生成并鉴定针对 SARS-CoV-2 的人源化协同中和抗体。
J Med Virol. 2022 Aug;94(8):3791-3800. doi: 10.1002/jmv.27801. Epub 2022 May 7.
引用本文的文献
1
Evidence of antibodies against SARS-CoV-2 in wild mustelids from Brittany (France).布列塔尼（法国）野生鼬科动物中存在针对 SARS-CoV-2 的抗体证据。
Transbound Emerg Dis. 2022 Sep;69(5):e3400-e3407. doi: 10.1111/tbed.14663. Epub 2022 Jul 27.
本文引用的文献
1
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.SARS-CoV-2 中和抗体对全长刺突蛋白和受体结合域的反应。
J Immunol. 2021 Aug 1;207(3):878-887. doi: 10.4049/jimmunol.2100272. Epub 2021 Jul 23.
2
Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.丹麦农场水貂中出现的严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）5型变异株的适应性和恢复期抗体中和特性
Front Microbiol. 2021 Jun 25;12:698944. doi: 10.3389/fmicb.2021.698944. eCollection 2021.
3
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization.SARS-CoV-2 Y453F 变异 mink 变体显示出 ACE-2 亲和力的明显增加，但不会挑战抗体中和。
J Biol Chem. 2021 Jan-Jun;296:100536. doi: 10.1016/j.jbc.2021.100536. Epub 2021 Mar 11.
4
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.深度突变扫描 SARS-CoV-2 受体结合域揭示了折叠和 ACE2 结合的限制。
Cell. 2020 Sep 3;182(5):1295-1310.e20. doi: 10.1016/j.cell.2020.08.012. Epub 2020 Aug 11.
5
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.针对 SARS-CoV-2 刺突蛋白多个表位的强效中和抗体。
Nature. 2020 Aug;584(7821):450-456. doi: 10.1038/s41586-020-2571-7. Epub 2020 Jul 22.
Zotero 插件